BioMark Diagnostics Inc.
BioMark Diagnostics Inc.
Your view on BUX.CN
Overview
What the company does, where it operates, and who runs it.
About BioMark Diagnostics Inc.
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Rashid Ahmed Maula Bux
- Headquarters
- CA
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Rashid Ahmed Maula Bux
- Headquarters
- CA
BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.